Using approved MS drug Copaxone during pregnancy or breastfeeding does not appear to raise the risk of problems for the child ...

Copaxone (glatiramer acetate) may not be safe to receive while pregnant or breastfeeding. Certain factors, including the risks of fetal harm, may determine whether you can receive the drug during ...

Mylan’s long-awaited rival for Teva’s blockbuster multiple sclerosis drug Copaxone has been approved in the US, putting a large chunk of the Israeli firm’s revenues at risk. The timing could ...

known under the brand names Copaxone and Glatopa, via a drug safety communication on 22 January. The products already have warnings of immediate post-injection reaction, chest pain, localised fat ...

Many reactions have happened within 1 hour of using Copaxone/Glatopa. Some signs and symptoms may be the same as those of an ...